{"name":"Alimera Sciences","slug":"alimera-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"fluocinolone acetonide 190 micrograms","genericName":"fluocinolone acetonide 190 micrograms","slug":"fluocinolone-acetonide-190-micrograms","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"fluocinolone acetonide 190 micrograms","genericName":"fluocinolone acetonide 190 micrograms","slug":"fluocinolone-acetonide-190-micrograms","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPcEFkMlV0cDhoTDJpMmxqbnJXQllDcW5tMmFkb1BPd1FHcTBBOE1rUXh2QVBnTTV5WEl3ajRKRWQxUEtzM2I4YTFvMTRQYmpqMGx5NktQTGhHZEpGY2F4S0pZN25qS2Y4MG5JeWRQRHRsUnNqaHF6QnRKSnptbFpTSXJjaVIxYmJ4amFXbWp6VUZDa0tnQklhaU9fa2R4TTM1ZFJBcjRoNXNDOElHWHc?oc=5","date":"2024-09-23","type":"deal","source":"Eyes On Eyecare","summary":"ANI Pharmaceuticals officially acquires Alimera Sciences - Eyes On Eyecare","headline":"ANI Pharmaceuticals officially acquires Alimera Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQajZlZ2xmNDMyUkNYVXg0M296TWM4RHpDbUJncU1fd1FrMzJnQUcyYVU1OVNFaHRvcFQ2dmRqUWQwVmF4aVZ3aEtBY3VaVVNQZTVuenhQQ2dvRExmdk51b3RvRFR5LUNGY0hrZW9zN1l5VG5FSnRMeFF1WkxFTTBFLUJoclhiYnBrNzZLNWJlczA1S1hQMXE2WlpWRFc4MEFVbzBKX0RyUVZRR1BfVUZGejRLcWJ3Zlp6UFZlRTZtZU8?oc=5","date":"2024-09-18","type":"pipeline","source":"roi-nj.com","summary":"Princeton-based ANI Pharmaceuticals completes acquisition of Alimera Sciences - roi-nj.com","headline":"Princeton-based ANI Pharmaceuticals completes acquisition of Alimera Sciences - roi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNTVBRTUtCVndTTVVVZXpqUUo5RkhoYk1ON0ZLcUZ4WFAxV2VqWk9UZkxNOHNsV2pvcExQal9hakFJS09LM3VUR2xXc1JFNmh2Q2RGN1JHRjVIUkZ2WmpqbEQ2aHU2VnVYQjJVV1BKTGh0Uml1SzBmUml1SHdtNEFmTkU2enpWR1lIbWt3QzJ0amZQcnBqZThTS001MFBvei1fczhUWE53QnRIWVI3M3hQOUxB?oc=5","date":"2024-09-17","type":"pipeline","source":"Healio","summary":"ANI Pharmaceuticals completes acquisition of Alimera Sciences - Healio","headline":"ANI Pharmaceuticals completes acquisition of Alimera Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQeFJjaThyemZCajNreVZRNzJ1S2xBY2kyQkJCMVA5M051Y2VkQ3IwcXZDOTg5NkwxTXd3LUtJTGxPQ3E0SWFzbFBrNEF0eDR3c1dFeFFuM3pqUHFGOGhtOVdYdGdvZGxaWWNkMUg5SWxMOWVLNnFYNVRSZ2hDb1dlSlRZQWM?oc=5","date":"2024-09-12","type":"pipeline","source":"Yahoo Finance","summary":"Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven? - Yahoo Finance","headline":"Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOS2I1a3ZXVUJNY2JVakhvUkhtUG1pS1hwSWpXNjdlcFlQLVdqNnA4cmpoT3hqek0ySG1aUDNrQ3hNcXpEV3hIRFdVN1QwQUpTc0ZJcm1sekFkaUU5amRhMVdCbkt6VV9IbXdGa0pnWW1QN0pHYmw0RHZJSTJsWlliYmdvNDQzOWI0aVZ2R2Rxc2pyUXNadEZKajBDUnY0TVE3V3lDSXZLU0J1TmE0c3N4cTAydHA?oc=5","date":"2024-09-11","type":"deal","source":"Drug Store News","summary":"Alimera Sciences takes legal action against ANI Pharmaceuticals to enforce merger agreement - Drug Store News","headline":"Alimera Sciences takes legal action against ANI Pharmaceuticals to enforce merger agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQek9tdzM0TFNWOVhQVkhVRG8zRmQ1UE1iaHpXSlU2ZU5UZVlhVjE5UzJKaVloWDctRWJYb250TURjclVId0Q4Y2tyOVBmcjA5LTlKUWJ2Q3JQMC1nZkM1NWxrWFF3NkUtX2JCRTRQcm1abjNQOWNmZTkya1pxRjU1bFpGNDV4b3dUTEphdjdXTDltUVVnMnFkc2p3?oc=5","date":"2024-06-24","type":"regulatory","source":"Fierce Pharma","summary":"ANI scoops up Alimera, 2 approved ophthalmology meds for $381M-plus - Fierce Pharma","headline":"ANI scoops up Alimera, 2 approved ophthalmology meds for $381M-plus","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNQUZGaVJ3cnZKUmZESnpXYm56YVVjbmpHWUpVdFNWLXBxck55QklXUUZ0N2pTWUUzNWlRZXhGMjZVRTBzTnZLbUoyTlhiQkF3VUpqYXVBRFBrMWN5WWJ6d25jNUphRW90SDRmMWkzQkl1RWJmTXRnN3lxdXFNOFVZVG5MdWJnWmxRTGtvRnJMU0RIV0VFWWZvMGMyYVJkcDJGUnJuZUh4NzRuQ2hBLWEySk9XNFNENEhTblpHMlM5THZkTWZDRUNhVVlDYndPN0Rl?oc=5","date":"2024-06-24","type":"pipeline","source":"Ophthalmology Times","summary":"ANI Pharmaceuticals to expand footprint into ophthalmology with acquisition of Alimera Sciences - Ophthalmology Times","headline":"ANI Pharmaceuticals to expand footprint into ophthalmology with acquisition of Alimera Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPTGRubENkM0E3VjBwVHVIbDhhV1NQcm5MeFJ0S1FRZXlQZ1AxeDd2b041SloxS2ZNX3RfNThsVWhEd2pFUXQyeXR0UDJlLTdYQzIwTmFXSXJ2ZlBaOWpNUjU2SkhSeW5MNEQtXzJXQ3JhRzIzTTVSVDA3Z3hBY3RpdmhpWW1TX0c1dEc0T2dzWnFsU0RULUJKeFAwbmdLZjQ0MGRrRHczNXRZN2JyWnlN?oc=5","date":"2024-06-24","type":"deal","source":"Pharmaceutical Technology","summary":"Alimera Sciences shares jump by 77% after being acquired by ANI - Pharmaceutical Technology","headline":"Alimera Sciences shares jump by 77% after being acquired by ANI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPRldYdHVqM193ZmFHd0dCWmw2S2RITFBWdnZXeHZMRDRTbVhqWWVkVlppSFl2eEgwcEdvOGlqYzJEZXlGVW95N04wc2VyZmFjSHhZZlFwU2JIdm55S3NndTN6R0ZiSzNNS1ZNQW95MHpwRGtqcU9tUzhQc29OczFGVlUtMFM2YU9QUFNMZFhpcV8xU3hvSE9xeQ?oc=5","date":"2024-06-24","type":"deal","source":"Contract Pharma","summary":"ANI Pharmaceuticals to Acquire Alimera Sciences - Contract Pharma","headline":"ANI Pharmaceuticals to Acquire Alimera Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNTHI1WTB0Y3gxd01ybmZYUWxFZ0k0OFF6YVduVlZPUF85Wmg0T0x5V2VBd1o4dV9pWERzWmtwZjRjTTc1M3NUcElpRGhTVTc5MVRMWG9kZnNudHNHbGxucWo0Yi1wMGFueUY4dS1Zc1RvNzd6LUdLSXBJcTlnYVBoSFRGRTVWSmp0VEZZamVvbGhDNEYxSjhyYTlNWDRQeWNwTFlOckJnYnozZ0tVM0N6UEI4c0dLMXpKaHBQRUlrbm5jbEpoQVY5ZENGMzdDRXoxWVJTT2ZnUVdUYUFGSm5SOVRFOFhaNzFMY25BdFZjUzItQ1ZaWHNyci1QTmRudUEw?oc=5","date":"2024-06-24","type":"pipeline","source":"GlobeNewswire","summary":"ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences - GlobeNewswire","headline":"ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPLThiSHlTR2R5UDN2YXNma084amYwQXZMODdnaENyMVM4djNPZXVFd0l2aVNqczdsWEhlUjhETjEyVkJLWEVUWWJtUzNDdnIwV3ZkcEY1bFZQalQ3QXBHOW96T0ZjVzZmN3h5N3RwUm9XVW5OY19NVnZFZEd0OTdEU25VZG5qaVZmdUg2cTE3VQ?oc=5","date":"2024-06-24","type":"pipeline","source":"Star Tribune","summary":"ANI Pharmaceuticals bolsters rare disease business with $381M eye care company acquisition - Star Tribune","headline":"ANI Pharmaceuticals bolsters rare disease business with $381M eye care company acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPaFdHWkNjZTNhYWZaVHVlVDVweFpBVVZlMG83UUswWTFyaEVkbGJpVTg4VVR3MWdXQWtLbGVpaEEySGVMSlZKZFB3TUtTNy1DQnhYU2F5XzNQdlpkZ0lQeGNLMlRVMlRLRXhTNkNmSjF6MmJRQlZCZ2MxWGIySmdfVEtaOGZoTklONGNYazctUnlUZHU1WnNsNWk5dTVfcElsOUlFM3dDakV6cERabHNfRlllaHZ1SlhnSTBsR0VlXzRSSHprYzhNUGVB?oc=5","date":"2023-05-18","type":"pipeline","source":"Modern Retina","summary":"EyePoint Pharmaceuticals sells YUTIQ® to Alimera Sciences, Inc. for $82.5 million (USD) plus royalties - Modern Retina","headline":"EyePoint Pharmaceuticals sells YUTIQ® to Alimera Sciences, Inc. for $82.5 million (USD) plus royalties","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}